版本:
中国

BRIEF-Protagonist Therapeutics Q4 net loss per share $0.67

March 7 Protagonist Therapeutics Inc:

* Protagonist Therapeutics reports fourth quarter and year-end 2016 financial results

* Qtrly net loss per share attributable to common stockholders $0.67

* Company reported net loss of $11.2 million for Q4 2016, as compared to a net loss of $5.5 million for Q4 2015

* Protagonist Therapeutics Inc- "increase in net loss was driven primarily by research and development expenses related to PTG-100 clinical trials" Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐